CVS Health CEO Karen Lynch has stepped down with company shares sinking 19% this year and the health care giant struggling on ...

More than 60 Houston neighborhoods don't have a single pharmacy, making access more difficult for those who depend on ...

Some CVS workers in Southern California are protesting over what they call unfair labor practices, and more employees are ...

Boeing's operational issues may be temporary, but its brand strength is unmatched. Discover more about BA stock and why it’s ...

Cigna has brought merger talks with Humana back from the dead, according to a new report in Bloomberg.

The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...

A Senate report published Thursday blasts the nation’s three largest Medicare Advantage insurers for increasingly limiting access to post-acute care and forcing vulnerable patients into “impossible ...

CVS Health (NYSE: CVS) has appointed a new president and CEO. David Joyner stepped into the role on Oct. 17, succeeding Karen Lynch. Joyner also joined ...

The Senate Homeland Security Permanent Subcommittee on Investigations (PSI) released a report on Thursday revealing that the nation’s three largest ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

Leadership overhaul and disappointing Q3 projections shake investor confidence as CVS faces rising cost pressures ...

The shift in management is not surprising as the company looks to level set its operations and strategically position itself ...